Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome

S Ren, J Attia, SC Li, D Newby - Vaccine, 2021 - Elsevier
Objective There is evidence that the pneumococcal polysaccharide vaccine (PPV) may
reduce cardiovascular disease. We aimed to evaluate the cost-effectiveness of PPV for …
被引用次数：2 相关文章

Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome

S Ren, J Attia, SC Li, D Newby - Vaccine, 2021 - pubmed.ncbi.nlm.nih.gov
Objective There is evidence that the pneumococcal polysaccharide vaccine (PPV) may
reduce cardiovascular disease. We aimed to evaluate the cost-effectiveness of PPV for …

Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome.

S Ren, J Attia, SC Li, D Newby - 2021 - cabidigitallibrary.org
Objective: There is evidence that the pneumococcal polysaccharide vaccine (PPV) may
reduce cardiovascular disease. We aimed to evaluate the cost-effectiveness of PPV for …

Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome.

S Ren, J Attia, SC Li, D Newby - Vaccine, 2021 - europepmc.org
Objective There is evidence that the pneumococcal polysaccharide vaccine (PPV) may
reduce cardiovascular disease. We aimed to evaluate the cost-effectiveness of PPV for …

[引用][C] Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome

S Ren, J Attia, SC Li, D Newby - 2021